ICMR invites companies to develop vaccines, diagnostic kits for monkey pox
According to WHO, monkeypox is a viral zoonosis – a virus transmitted to humans from animals – with symptoms similar to smallpox…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Bangladesh’s maiden homegrown COVID-19 vaccine gets clearance for human trials
The Bangavax vaccine, developed by local pharma company Globe Biotech, recently received clearance from the Directorate General of…
New data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular…
In the Tenaya and Lucerne studies, more than 60 per cent of Vabysmo patients could be treated every four months at two years. This…
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric…
The trial administered to adult COVID-19 patients in India met the key endpoints and demonstrated reductions of viral load of 94…
Novartis’s tislelizumab phase-III trial data shows survival results in esophageal cancer
First-line tislelizumab plus chemotherapy showed median Overall Survival (OS) of 17.2 months versus 10.6 months for chemotherapy…
Sanofi, GSK COVID-19 vaccine found effective against Omicron
The vaccine targets the beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus
Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with…
Ahammune’s investigational new drug for vitiligo- AB1001 has mechanism of action that targets pathways involved in triggering…
Merck presents positive results from phase-II/III study
Broad phase-III clinical programme for V116 in vaccine-naïve and vaccine-experienced adults planned to start in July 2022
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years
Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
Parexel launches new community alliance network
The initiative seeks to expand patient access to clinical trials
Researchers at University of Strathclyde call for delay in clinical trials for gel stroke treatments
The researchers claim that failure to do so could have “devastating” effects on the prospects for the treatments being used for…
BSV enters into research partnership with National Chemical Laboratory, Pune
The collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharma…
GARDP and Bugworks collaborate to assess safety of new antibiotic compound
The support of the cardiac safety study of Bugworks' lead molecule BWC0977, currently going through Phase 1 studies in Adelaide…
Takeda’s dengue vaccine candidate provides continued protection against dengue fever through 4.5…
In long-term exploratory analysis, TAK-003 prevented 84 per cent of hospitalisations and 61 per cent of symptomatic dengue illness…
Cancer disappears from every patient’s body in drug trial in US: Report
Besides their tumours disappearing completely, none of the participants reported any severe side-effects either, says the research…
Clinical trials 2021 report reveals double-rate growth from pre-pandemic levels
The "2021 Completed Trials" report by Pharma Intelligence, indicates an 8.8 per cent annual increase in sponsored clinical trials
57 per cent of organisations in India are at startup stage of genomics high-performance computing…
A whitepaper by Lenovo and Intel, led by IDC, has underlined humanity’s greatest challenges where genomics research-led…
New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-…
Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…
Entod Pharma gets DCGI nod to carry out phase-III trial of Atropine eye drops
Subject to a successful demonstration of safety and efficacy in clinical studies, Entod Pharma would be the first company to…
Immune modulator drugs improves survival for people hospitalised with COVID-19
NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…